News-Medical.Net on MSN

RION engages Lonza to scale manufacturing exosome based therapeutics

RION, a commercial and clinical-stage regenerative medicine company pioneering platelet-derived exosomes for both human and ...
Contract Pharma

RION Partners with Lonza for Scalable Exosome-Based Drug Manufacturing

RION has engaged Lonza to provide cGMP manufacturing and technical support for commercial-scale production of Rion’s PEP drug ...

Jim Cramer Says Maybe A Merger Would Solve PepsiCo, Inc. (PEP)’s Problems

We recently published 13 Stocks That Jim Cramer Discussed. PepsiCo, Inc. (NASDAQ:PEP) is one of the stocks Jim Cramer recently discussed. PepsiCo, Inc. (NASDAQ:PEP)’s been quite notorious lately as ...
GEN - Genetic Engineering and Biotechnology News

Lonza Agrees to Scale Manufacturing for RION’s Exosome-Based Therapeutics

RION officials say the company developed a proprietary biomanufacturing platform enabling scaled production of platelet-derived exosomes. This platform allows for the advancement of RION’s pipeline of ...